Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology

Journal of Nuclear Cardiology

Volumn 18, Issue 1, 2011, Pages 135-143

  Tamaki, Nagara ^a   Yoshinaga, Keiichiro ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

BMIPP; heart failure; metabolism: SPECT; MIBG imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IODOFILTIC ACID I 123; NEURONAL TRACT TRACER; TECHNETIUM 99M; THALLIUM 201;

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG RETENTION; DRUG TISSUE LEVEL; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN RESISTANCE; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SYMPATHETIC FUNCTION;

3-IODOBENZYLGUANIDINE; CARDIOLOGY; CARDIOVASCULAR DISEASES; FATTY ACIDS; HUMANS; IMAGE ENHANCEMENT; IODOBENZENES; MOLECULAR IMAGING; NUCLEAR MEDICINE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 79951671213     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9305-4     Document Type: Review

References (98)

1. JC Wu FM Bengel SS Gambhir 2007 Cardiovascular molecular imaging Radiology 244 337 355 10.1148/radiol.2442060136 17592037 (Pubitemid 47080867)
2. AJ Sinusus F Bengel M Nahrendorf FH Epstein JC Wu FS Villanueva ZA Fayad RJ Gropler 2008 Multimodality cardiovascular molecular imaging. Part I Circ Cardiovasc Imaging 1 244 256 10.1161/CIRCIMAGING.108.824359
3. FM Bengel T Higuchi M Javadi R Lautamaki 2009 Cardiac positron emission tomography J Am Coll Cardiol 54 1 15 10.1016/j.jacc.2009.02.065 19555834
4. WM Manger BB Hoffman 1983 Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake [teaching editorial] J Nucl Med 24 1194 1196 1:STN:280:DyaL2c%2Fmtl2jtg%3D%3D 6644382 (Pubitemid 14218718)
5. MC Tobes S Jacques DM Wieland JC Sisson 1985 Effect of uptake one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine J Nucl Med 26 897 907 1:CAS:528:DyaL28XhsVCksrk%3D 3162008 (Pubitemid 16001493)
6. 123I]iodobenzylguanidine in isolated rat heart Nucl Med Biol 22 1 12 1:CAS:528:DyaK2MXkslGisbY%3D 10.1016/0969-8051(94)00084-W 7735158
7. Y Inoue A Suzuki I Shirouzu T Machida Y Yoshizawa F Akita S Ohnishi K Yoshikawa KJ Ohtomo 2003 Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake J Nucl Cardiol 10 623 632 10.1016/S1071- 3581(03)00652-4 14668774 (Pubitemid 38035397)
8. MA Pfiffer E Braunwald LA Moye, et al. 1992 Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 669 677 10.1056/ NEJM199209033271001
9. S Matsuo K Nakajima S Yamashina K Sakata M Momose J Hashimoto S Kumita M Kawano K Okuda 2009 Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging Ann Nucl Med 23 517 522 10.1007/s12149-009-0269-x 19521747
10. M Packer MR Bristow JN Cohn, et al. 1996 The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1349 1355 1:CAS:528: DyaK28Xjs1Wjtbw%3D 10.1056/NEJM199605233342101 8614419 (Pubitemid 26152713)
11. JN Cohn TB Levine MT Olivari, et al. 1984 Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 819 823 1:STN:280:DyaL2c3psFCksg%3D%3D 10.1056/NEJM198409273111303 6382011 (Pubitemid 14035089)
12. C Hall JL Rouleau L Moye, et al. 1994 N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction Circulation 89 1934 1942 1:STN:280:DyaK2c3js1Omsg%3D%3D 8181115
13. T Omland A Aakvaag VV Bonarjee, et al. 1996 Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1963 1969 1:CAS:528:DyaK28XktlyktL8%3D 8640969
14. T Tsutamoto A Wada K Maeda, et al. 1997 Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 509 516 1:STN:280:DyaK2szos1eksg%3D%3D 9244219 (Pubitemid 27329427)
15. MR Bristow R Ginsburg W Minobe, et al. 1982 Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 307 205 211 1:CAS:528:DyaL38XkvV2qsrc%3D 10.1056/NEJM198207223070401 6283349 (Pubitemid 12079105)
16. MB Fowler JA Laser GL Hopkins W Minobe MR Bristow 1986 Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response Circulation 74 1290 1302 1:STN:280:DyaL2s%2Flt1Smuw%3D%3D 3022962 (Pubitemid 17189248)
17. RR Ruffolo Jr GA Kopia 1986 Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure Am J Med 80 67 72 10.1016/0002-9343(86)90148-8 2868661 (Pubitemid 16012626)
18. P Merlet J Delforge A Syrota, et al. 1993 Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy Circulation 87 1169 1178 1:STN:280: DyaK3s3hsFSmtQ%3D%3D 8096441 (Pubitemid 23110389)
19. T Tsukamoto K Morita M Naya M Inubushi C Katoh K Nishijima Y Kuge H Okamoto H Tsuitsui N Tamaki 2007 Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy J Nucl Med 48 1777 1782 1:CAS:528:DC%2BD2sXhsVSitrzN 10.2967/jnumed.107.043794 17942801 (Pubitemid 350099321)
20. DM Wieland LE Brown WL Rogers, et al. 1981 Myocardial imaging with a radioiodinated norepinephrine storage analog J Nucl Med 22 22 31 1:STN:280:DyaL3M%2FpsF2msQ%3D%3D 7452352 (Pubitemid 11213140)
21. EB Henderson JK Kahn JR Corbett, et al. 1988 Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy Circulation 78 1192 1199 1:STN:280:DyaL1M%2FivFSgsQ%3D%3D 3180378
22. J Schofer R Spielmann A Schuchert K Weber M Schluter 1988 Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 12 1252 1258 1:STN:280: DyaL1M%2FgvFaruw%3D%3D 10.1016/0735-1097(88)92608-3 3170968
23. JV Glowniak FE Turner LL Gray RT Palac MC Lagunas-Solar WR Woodward 1989 Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants J Nucl Med 30 1182 1191 1:STN:280:DyaL1M3ptlensw%3D%3D 2661758 (Pubitemid 19175977)
24. P Merlet JL Dubois-Rande S Adnot, et al. 1992 Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy J Cardiovasc Pharmacol 19 10 16 1:CAS:528: DyaK38XotFeluw%3D%3D 10.1097/00005344-199201000-00002 1375674
25. P Merlet F Pouillart JL Dubois-Rande, et al. 1999 Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart J Nucl Med 40 224 231 1:STN:280:DyaK1M7kvVKqtg%3D%3D 10025827 (Pubitemid 29077082)
26. A Cohen-Solal F Rouzet A Berdeaux, et al. 2005 Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure J Nucl Med 46 1796 1803 1:CAS:528:DC%2BD28XitVGltL4%3D 16269592 (Pubitemid 46196640)
27. P Merlet C Benvenuti D Moyse, et al. 1999 Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy J Nucl Med 40 917 923 1:STN:280:DyaK1MznvFektw%3D%3D 10452306 (Pubitemid 29269210)
28. P Merlet H Valette JL Dubois-Rande, et al. 1992 Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 471 477 1:STN:280:DyaK383gt12rtA%3D%3D 1552326
29. M Momose H Kobayashi N Iguchi, et al. 1999 Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy Nucl Med Commun 20 529 535 1:STN:280:DyaK1MzotFWksA%3D%3D 10.1097/00006231-199906000-00007 10451865 (Pubitemid 29509990)
30. T Yamada T Shimonagata M Fukunami, et al. 2003 Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study J Am Coll Cardiol 41 231 238 10.1016/S0735-1097(02)02700-6 12535815 (Pubitemid 36092191)
31. T Nakata K Miyamoto A Doi H Sasao T Wakabayashi H Kobayashi K Tsuchihashi K Shimamoto 1998 Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts J Nucl Cardiol 5 579 590 1:STN:280:DyaK1M%2FosVyhtw%3D%3D 10.1016/S1071-3581(98) 90112-X 9869480 (Pubitemid 29015414)
32. T Nakata T Wakabayashi M Kyuma T Takahashi A Hashimoto H Ogata 2003 Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction J Card Fail 9 113 121 1:CAS:528:DC%2BD3sXjsVejt7Y%3D 10.1054/jcaf.2003.14 12751132 (Pubitemid 36444196)
33. M Kyuma T Nakata A Hashimoto K Nagao H Sasao T Takahashi K Tsuchihashi K Shimamoto 2004 Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure J Nucl Med 45 155 163 1:CAS:528:DC%2BD2cXitVCrtLk%3D 14960630 (Pubitemid 47628373)
34. Y Imamura T Fukuyama T Mochizuki M Miyagawa K Watanabe Ehime MIBG Heart Failure Study Investigators 2001 Prognostic value of Iodine-123- metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy Jpn Circ J 65 155 160 1:CAS:528:DC%2BD3MXitV2rurY%3D 10.1253/jcj.65.155 11266187 (Pubitemid 32225193)
35. 123I-metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function Ann Nucl Med 18 591 598 10.1007/BF02984581 15586633 (Pubitemid 39612243)
36. D Agostini HJ Verberne W Burchert J Knuuti P Povinec G Sambuceti M Unlu M Estorch G Banerjee AF Jacobson 2008 I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: Insights from a retrospective European multicenter study Eur J Nucl Med Mol Imaging 35 535 546 10.1007/s00259-007-0639-3 18043919
37. S Tamaki T Yamada Y Okuyama T Morita S Sanada Y Tsukamoto M Musda K Okuda Y Iwasaki T Yasui M Hori M Fukunami 2009 Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction J Am Coll Cardiol 53 426 435 1:CAS:528:DC%2BD1MXhtlShsbc%3D 10.1016/j.jacc.2008.10.025 19179201
38. M Brunner X Peng GX Liu XQ Ren O Ziv BR Choi R Mathur M Hajjiri KE Odening E Steinberg EJ Folco E Pringa J Centracchio RR Macharzina T Donahay L Schofield N Rana M Kirk GF Mitchell A Poppas M Zehender G Koren 2008 Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome J Clin Invest 118 2246 2259 1:CAS:528:DC%2BD1cXntVCmu7s%3D 18464931 (Pubitemid 351872342)
39. 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review Eur Heart J 29 1147 1159 10.1093/eurheartj/ehn113 18349024 (Pubitemid 351844881)
40. 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: A need for standardisation and validation Eur J Nucl Med Mol Imaging 35 547 553 1:CAS:528:DC%2BD1cXjvFOgt7g%3D 10.1007/s00259-007-0611-2 17922122 (Pubitemid 351661673)
41. M Suwa Y Otake A Moriguchi, et al. 1997 Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy Am Heart J 133 353 358 1:CAS:528:DyaK2sXitFarurg%3D 10.1016/S0002-8703(97)70232-1 9060806
42. H Kakuchi T Sasaki Y Ishida K Komamura K Miyatake 1999 Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment Heart 81 148 152 1:STN:280:DyaK1M7jtVaiuw%3D%3D 9922349 (Pubitemid 29119388)
43. N Spyrou SD Rosen F Fath-Ordoubadi, et al. 2002 Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months J Am Coll Cardiol 40 1216 1224 1:CAS:528:DC%2BD38Xot1WgsL4%3D 10.1016/S0735-1097(02)02162-9 12383568
44. M Naya T Tsukamoto K Morita C Katoh K Nishijima H Komatsu S Yamada Y Kuge N Tamaki H Tsuitsui 2009 Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy J Nucl Med 50 220 225 1:CAS:528:DC%2BD1MXjt1Clsb4%3D 10.2967/jnumed.108.056341 19164238
45. M Josephson HJ Wellens 2004 Implantable defibrillators and sudden cardiac death Circulation 109 2685 2691 10.1161/01.CIR.0000129322.97266.F3 15184292 (Pubitemid 38737911)
46. AE Epstein JP DiMarco KA Ellenbogen, et al. 2008 ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 e1 e62 10.1016/j.jacc.2008.02.032 18498951 (Pubitemid 351689050)
47. AJ Moss H Greenberg RB Case, et al. 2004 Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implantable defibrillator Circulation 110 3760 3765 10.1161/01.CIR.0000150390.04704.B7 15583079 (Pubitemid 40023973)
48. GH Bardy KL Lee DB Mark, et al. 2005 Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Eng J Med 352 225 237 1:CAS:528:DC%2BD2MXmslShtw%3D%3D 10.1056/NEJMoa043399 (Pubitemid 40110811)
49. R Tung P Zimetbaum ME Josephson 2008 A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 1111 1121 10.1016/j.jacc.2008.05.058 18804736
50. RJ Myerburg V Reddy A Castellanos 2009 Indications for implantable cardioverter-defibrillators based on evidence and judgment J Am Coll Cardiol 54 747 763 10.1016/j.jacc.2009.03.078 19695452
51. PJ Podrid T Fuchs R Candinas 1990 Role of the sympathetic nervous system in the genesis of ventricular arrhythmia Circulation 822 I103 I113
52. DP Zipes 1991 Sympathetic stimulation and arrhythmias N Eng J Med 325 656 657 1:STN:280:DyaK3MzhvFWrtg%3D%3D 10.1056/NEJM199108293250911
53. RD Mitrani LS Klein WM Miles, et al. 1993 Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease J Am Coll Cardiol 22 1344 1353 1:STN:280:DyaK2c%2FksVansg%3D%3D 10.1016/0735-1097(93)90541-8 8227790 (Pubitemid 23316357)
54. R Arora KJ Ferrick T Nakata, et al. 2003 I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator J Nucl Cardiol 10 121 131 10.1067/mnc.2003.2 12673176 (Pubitemid 36503797)
55. D Nagahara T Nakata A Hashimoto, et al. 2008 Predicting the need of an implantable cardioverter defibrillator using metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function J Nucl Med 49 225 233 10.2967/jnumed.107.042564 18199625 (Pubitemid 351225660)
56. JJ Bax O Kraft AE Buxton, et al. 2009 123I-MIBG scintigraphy to predict testing. A prospective multicenter pilot study Circ Cardiovasc Imaging 1 131 140 10.1161/CIRCIMAGING.108.782433
57. 123I-mIBG imaging and cardiac events in heart failure: Results of the prospective ADMIRE-HF study J Am Coll Cardiol 55 2212 2221 10.1016/j.jacc.2010.01.014 20188504
58. HW Strauss MN Johnson H Schoder N Tamaki 2010 Metaiodobenzylguanidine imaging comes of age J Am Coll Cardiol 55 2222 2224 10.1016/j.jacc.2010.02.023 20466202
59. MJ Boogers JW Borleffs MM Henneman RJ van Bommel J van Ramshort E Boersma PD Schneider MP Stokkel EE van der Wall MJ SChalij JJ Bax 2010 Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter defibrillator patients J Am Coll Cardiol 55 2769 2777 10.1016/j.jacc.2009.12.066 20538172
60. K Nishisato A Hashimoto T Nakata T Doi H Yamamopto D Nagahara S Shimoshige S Yuda K Tsuchihashi K Shimamoto 2010 Impaired cardiac sympathetic innervations and myocardial perfusion are related to lethal arrhythmia: Quantification of cardiac tracers in patients with ICDs J Nucl Med 51 1241 1249 10.2967/jnumed.110.074971 20679471
61. FF Knapp Jr MM Goodman AP Callahan, et al. 1986 Radioiodinated 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid: A useful new agent to evaluate myocardial fatty acid uptake J Nucl Med 27 521 531 1:CAS:528:DyaL28XlsVyqtr8%3D 3712065 (Pubitemid 17028127)
62. N Tamaki Y Fujibayashi Y Magata, et al. 1995 Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT J Nucl Cardiol 2 256 266 1:STN:280:DyaK1c%2Fot1eltA%3D%3D 10.1016/S1071-3581(05)80063-7 9420796
63. N Tamaki K Morita Y Kuge E Tsukamoto 2000 The role of fatty acids in cardiac imaging J Nucl Med 41 1525 1534 1:CAS:528:DC%2BD3cXntFOhtLw%3D 10994734
64. N Tamaki K Morita Y Kawai 2007 The Japanese experience with metabolic imaging in the clinical setting J Nucl Cardiol 14 S145 S152 10.1016/j.nuclcard. 2007.02.012 17556183 (Pubitemid 46840321)
65. Y Kawai E Tsukamoto Y Nozaki, et al. 1998 Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction Eur J Nucl Med 25 1390 1395 1:STN:280:DyaK1M%2FjsFKrtg%3D%3D 10.1007/s002590050313 9818278 (Pubitemid 28464113)
66. K Nakajima K Schimizu J Taki, et al. 1995 Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina J Nucl Med 36 1934 1940 1:STN:280:DyaK28%2FkvFSrtA%3D%3D 7472578
67. Y Takeishi S Fujiwara H Atsumi, et al. 1997 Iodine-123-BMIPP imaging in unstable angina: A guide for interventional therapy J Nucl Med 38 1407 1411 1:STN:280:DyaK2svjvVShsQ%3D%3D 9293798 (Pubitemid 27386201)
68. S Fujiwara Y Takeishi H Atsumi, et al. 1997 Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease J Nucl Med 38 175 180 1:CAS:528:DyaK2sXhsFSku7s%3D 9025730 (Pubitemid 27061588)
69. M Tateno N Tamaki T Kudoh, et al. 1996 Assessment of fatty acid uptake in patients with ischemic heart disease without myocardial infarction J Nucl Med 37 1981 1985 1:STN:280:DyaK2s7isFCnsw%3D%3D 8970518 (Pubitemid 26428366)
70. A Suzuki Y Takada M Nagasaka, et al. 1997 Comparison of resting β-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina Jpn Circ J 61 133 138 1:STN:280:DyaK2s3isVGgtg%3D%3D 10.1253/jcj.61.133 9070968 (Pubitemid 27148957)
71. 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain Ann Nucl Med 14 187 192 1:STN:280: DC%2BD3M%2FivF2lsg%3D%3D 10.1007/BF02987858 10921483 (Pubitemid 30485353)
72. Y Kawai E Tsukamoto Y Nozaki K Morita M Sakurai N Tamaki 2001 Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain J Am Coll Cardiol 38 1888 1894 1:CAS:528:DC%2BD38XisFalsQ%3D%3D 10.1016/S0735-1097(01)01634-5 11738290 (Pubitemid 33116560)
73. K Watanabe T Takahashi S Miyajima, et al. 2002 Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina J Nucl Med 43 1476 1481 1:CAS:528:DC%2BD38XptV2mt7g%3D 12411551 (Pubitemid 35285873)
74. Y Inaba SR Bergmann 2008 Diagnostic accuracy of beta-methyl-para-[123I]- iodophenyl-pentadecanoic acid (BMIPP) imaging: A meta-analysis J Nucl Cardiol 15 345 352 10.1016/j.nuclcard.2008.02.019 18513641
75. 99mTc-tetrofosmin SPECT and Coronary angiography Circ J 68 547 552 10.1253/circj.68.547 15170090 (Pubitemid 38856029)
76. MC Kontos V Dilsizian F Weiland G DePuey JJ Mahmarian AE Iskandrian TM Bateman GV Heller K Ananthasubramaniam Y Li JL Goldman T Armor KA Kacena N LaFrance EV Garcia JW Bbich JE Udelson 2010 Iodofiltic acid I-123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes J Am Coll Cardiol 56 290 299 10.1016/j.jacc.2010.03.045 20633821
77. V Dilsizian TM Bateman SR Bergmann R Des Prez MY Magram AE Goodbody JW Babich JE Udelson 2005 Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl- pentadecanoic acid identifies ischemic memory after demand ischemia Circulation 112 2169 2174 10.1161/CIRCULATIONAHA.104.530428 16186423 (Pubitemid 41475812)
78. N Tamaki E Tadamura T Kudoh, et al. 1996 Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction Eur J Nucl Med 23 272 279 1:STN:280:DyaK287ntFantw%3D%3D 10.1007/BF00837625 8599958 (Pubitemid 26089893)
79. T Nakata T Kobayashi N Tamaki, et al. 2000 Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction Nucl Med Commun 21 897 907 1:CAS:528:DC%2BD3cXos1yjsr4%3D 10.1097/00006231-200010000- 00003 11130330
80. S Fukuzawa S Ozawa K Shimada, et al. 2002 Prognostic values of perfusion-metabolic mismatch in Tl-201 and BMIPP scintigraphic imaging in patients with chronic coronary artery disease and left ventricular dysfunction undergoing revascularization Ann Nucl Med 16 109 115 10.1007/BF02993713 12043904 (Pubitemid 34547117)
81. M Nanasato H Hirayama A Ando S Isobe M Nonokawa Y Kinoshita I Nanbu M Yokota T Murohara 2004 Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention Eur J Nucl Med Mol Imaging 31 1512 1521 10.1007/s00259-004-1556-3 15232655 (Pubitemid 39592772)
82. T Matsuki N Tamaki T Nakata, et al. 2004 Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: Comparison with stress thallium imaging Eur J Nucl Med Mol Imaging 31 1585 1591 10.1007/s00259-004-1551-8 15583913 (Pubitemid 40104603)
83. T Chikamori H Fujita M Nanasato M Toba T Nishimura 2005 Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease J Nucl Cardiol 12 172 178 10.1016/j.nuclcard.2004.12.293 15812371 (Pubitemid 40450767)
84. Y Inaba SR Bergmann 2010 Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systemic review J Nucl Cardiol 17 61 70 10.1007/s12350-009-9157-y 19851821
85. SG Rostand EA Rutsky 1989 Ischemic heart disease in chronic renal failure: Management considerations Semin Dial 2 98 101 10.1111/j.1525-139X.1989. tb00566.x
86. D Ansell P Roderick A Hodsman, et al. 2009 UK Renal Registry 11th annual report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: National and centre-specific analyses Nephron Clin Pract 111 c113 c139 10.1159/000209996 19542694
87. RN Foley PS Parfrey MJ Sarnak 1998 Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 S16 S23 1:STN:280: DC%2BD3MzovF2lug%3D%3D 11443763
88. RA DeFronzo A Alvestrand D Smith, et al. 1981 Insulin resistance in uremia J Clin Invest 67 563 568 1:CAS:528:DyaL3MXotFOitw%3D%3D 10.1172/JCI110067 7007440 (Pubitemid 11141740)
89. SB Wheatcroft IL Williams AM Shah, et al. 2003 Pathophysiological implications of insulin resistance on vascular endothelial function Diabet Med 20 255 268 1:CAS:528:DC%2BD3sXjvVSjtbw%3D 10.1046/j.1464-5491.2003.00869.x 12675638 (Pubitemid 36606117)
90. ZY Jiang YW Lin A Clemont, et al. 1999 Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats J Clin Invest 104 447 457 1:CAS:528:DyaK1MXltlekurw%3D 10.1172/JCI5971 10449437 (Pubitemid 29534329)
91. BM Balletshofer K Ritting MD Enderle, et al. 2000 Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance Circulation 101 1780 1784 1:CAS:528:DC%2BD3cXjtVOntrY%3D 10769277 (Pubitemid 30213098)
92. AJ Jaap AC Shore JE Tooke 1997 Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycemia Diabetologia 40 238 243 1:CAS:528:DyaK2sXhtFaqsbk%3D 10.1007/s001250050669 9049487 (Pubitemid 27060299)
93. EH Serne CD Stehouwer JC ter Maaten, et al. 1999 Microvascular function relates to insulin sensitivity and blood pressure in normal subjects Circulation 99 896 902 1:CAS:528:DyaK1MXhslSqtrc%3D 10027812 (Pubitemid 29094303)
94. N Dagres B Saller M Haude, et al. 2004 Insulin sensitivity and coronary vasoreactivity: Insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects Clin Endocrinol 61 724 731 1:CAS:528: DC%2BD2MXltVWmtw%3D%3D 10.1111/j.1365-2265.2004.02156.x (Pubitemid 40006793)
95. M Nishimura T Hashimoto H Kobayashi T Fukuda K Okino N Yamamoto H Fujita N Ioue T Nishimura 2004 Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients Kidney Int 66 811 829 10.1111/j.1523-1755.2004.00808.x 15253738 (Pubitemid 38982026)
96. M Nishimura K Tsukamoto N Hasebe, et al. 2008 Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging J Am Coll Cardiol 51 139 145 1:CAS:528:DC%2BD1cXlsFequw%3D%3D 10.1016/j.jacc.2007.08.057 18191738
97. M Nishimura T Tokoro M Nishida, et al. 2008 Prediction of cardiac death after coronary revascularization by myocardial fatty acid imaging in hemodialysis patients Kidney Int 74 513 520 10.1038/ki.2008.211 18528325
98. 123I-BMIPP- SPECT: B-SAFE study design Ther Apher Dial 12 526 530 10.1111/j.1744-9987.2008. 00643.x 19140853